Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) saw a significant decrease in short interest in August. As of August 31st, there was short interest totaling 9,742 shares, a decrease of 55.2% from the August 15th total of 21,732 shares. Based on an average trading volume of 41,401 shares, the days-to-cover ratio is currently 0.2 days.
Ono Pharmaceutical Stock Up 0.2%
Shares of OPHLY stock opened at $5.01 on Tuesday. The stock has a fifty day moving average of $5.01 and a 200 day moving average of $5.00. Ono Pharmaceutical has a 52 week low of $3.71 and a 52 week high of $5.75.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty?pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co?developing and commercializing nivolumab (Opdivo), an anti–PD?1 immune checkpoint inhibitor developed in partnership with Bristol?Myers Squibb.
See Also
- Five stocks we like better than Ono Pharmaceutical
- 3 Defense Stocks Riding the High-Energy Laser Boom
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
